je.st
news
Biogen Idec and Sobi Announce European Medicines Agency Validates...
2014-10-31 22:14:45| Appliances - Topix.net
CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTAa , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.
Tags: agency
european
announce
medicines
Category:Consumer Goods and Services